HealthLynked Corp. Announces Board and Executive Changes
Ticker: HLYK · Form: 8-K · Filed: Mar 14, 2024 · CIK: 1680139
| Field | Detail |
|---|---|
| Company | Healthlynked Corp (HLYK) |
| Form Type | 8-K |
| Filed Date | Mar 14, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $150,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, executive-compensation
TL;DR
HealthLynked shuffled its board and exec pay. Big changes coming?
AI Summary
HealthLynked Corp. announced changes to its board of directors and executive compensation arrangements on March 11, 2024. The filing details the departure of certain officers and directors, the election of new directors, and adjustments to compensatory arrangements for key personnel. Specific details regarding the individuals involved and the financial implications of these changes are outlined within the report.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Changes in leadership and compensation can introduce uncertainty and potential strategic shifts, warranting closer investor scrutiny.
Key Players & Entities
- HealthLynked Corp. (company) — Registrant
- Nevada (jurisdiction) — State of incorporation
- March 11, 2024 (date) — Date of earliest event reported
FAQ
Who specifically departed from HealthLynked Corp.'s board or officer positions?
The filing indicates the departure of certain officers and directors, but specific names are not listed in the provided excerpt.
Were any new directors elected to the HealthLynked Corp. board?
Yes, the filing states that new directors were elected as part of the reported changes.
What specific compensatory arrangements were adjusted for HealthLynked Corp. officers?
The filing mentions adjustments to compensatory arrangements for certain officers, but the details of these arrangements are not provided in the excerpt.
What is the primary reason cited for these changes at HealthLynked Corp.?
The filing does not explicitly state a single primary reason for the changes, but it falls under the categories of director departures, elections, and officer compensation.
When was the earliest event reported in this 8-K filing for HealthLynked Corp.?
The earliest event reported in this filing occurred on March 11, 2024.
Filing Stats: 650 words · 3 min read · ~2 pages · Grade level 11.3 · Accepted 2024-03-14 16:00:11
Key Financial Figures
- $150,000 — ed that Mr. Rosal's base salary will be $150,000 per year, and that he will be eligible
Filing Documents
- ea0201822-8k_health.htm (8-K) — 24KB
- 0001213900-24-022598.txt ( ) — 187KB
- hlyk-20240311.xsd (EX-101.SCH) — 3KB
- hlyk-20240311_lab.xml (EX-101.LAB) — 33KB
- hlyk-20240311_pre.xml (EX-101.PRE) — 22KB
- ea0201822-8k_health_htm.xml (XML) — 3KB
02 Departure of Directors or Certain
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Appointment of Chief Financial Officer On March 11, 2024, HealthLynked Corp., a Nevada corporation (the " Company "), appointed David Rosal, age 61, as its Chief Financial Officer, effective immediately. Mr. Rosal previously served as Senior Industry Expert – CFO Analytics at Teradata in Fort Myers, FL, from June 2008 to November 2023. Before his time at Teradata, Mr. Rosal held several senior positions at McDonald's Corporation in Oak Brook, IL, including Director of Business Integration from January 2006 to December 2008, and Director of Concept Development from January 2000 to December 2006 and Director of Finance – East Division from November 1994 to December 1999. Mr. Rosal holds a Master of Business Administration in Business Administration from DePaul University, Chicago, IL (September 1988 to January 1992), and a Bachelor of Science in Accounting from Marquette University, Milwaukee, WI (September 1981 to May 1985). The Company and Mr. Rosal have agreed that Mr. Rosal's base salary will be $150,000 per year, and that he will be eligible to participate in the benefit plans and programs generally available to the Company's employees. Mr. Rosal will also be eligible to participate in the Company's 2021 Equity Incentive Plan (the " 2021 EIP "), pursuant to which Mr. Rosal will be entitled to awards. The number of awards granted to Mr. Rosal under the 2021 EIP will be determined based on his position, the length of his employment, and other relevant factors. There are no arrangements or understandings between Mr. Rosal and any other person pursuant to which he was selected for his position. In addition, there are no family relationships between Mr. Rosal and any directors or executive officers of the Company, and no transactions are required to be reported under Item 404(a) of Regulation S-K between M
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized. HEALTHLYNKED CORP. Date: March 14, 2024 /s/ Michael Dent Michael Dent Chief Executive Officer and Chairman 2